Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-02 Sale | 2025-04-03 5:00 pm | Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer | 2,189 | $4.15 | $9,084 | 25,657 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-04-01 Exercise | 2025-04-03 5:00 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer | 14,680 | $0 | 25,657 (Direct) | View |
| 2025-01-08 Option Award | 2025-01-10 09:00 am | N/A 2035-01-07 | Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer | 265,000 | $0 | 265,000 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:05 pm | N/A 2034-06-20 | Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer | 32,000 | $0 | 32,000 (Direct) | View |
Ownership | 2024-06-25 5:00 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer | 0 | $0 | 260,516 (Direct) | View |